185 related articles for article (PubMed ID: 1543541)
1. Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
Egawa S; Kadmon D; Miller GJ; Scardino PT; Thompson TC
Mol Carcinog; 1992; 5(1):52-61. PubMed ID: 1543541
[TBL] [Abstract][Full Text] [Related]
2. Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.
Thompson TC; Egawa S; Kadmon D; Miller GJ; Timme TL; Scardino PT; Park SH
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):79-85. PubMed ID: 1525069
[TBL] [Abstract][Full Text] [Related]
3. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer.
Baley PA; Yoshida K; Qian W; Sehgal I; Thompson TC
J Steroid Biochem Mol Biol; 1995 May; 52(5):403-13. PubMed ID: 7538321
[TBL] [Abstract][Full Text] [Related]
4. Experimental oncogene induced prostate cancer.
Thompson TC; Kadmon D; Timme TL; Merz VW; Egawa S; Krebs T; Scardino PT; Park SH
Cancer Surv; 1991; 11():55-71. PubMed ID: 1726789
[TBL] [Abstract][Full Text] [Related]
5. Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
Merz VW; Miller GJ; Krebs T; Timme TL; Kadmon D; Park SH; Egawa S; Scardino PT; Thompson TC
Mol Endocrinol; 1991 Apr; 5(4):503-13. PubMed ID: 1922083
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
Greene DR; Taylor SR; Aihara M; Yoshida K; Egawa S; Park SH; Timme TL; Yang G; Scardino PT; Thompson TC
Int J Cancer; 1995 Jan; 60(3):395-9. PubMed ID: 7829250
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.
Timme TL; Truong LD; Merz VW; Krebs T; Kadmon D; Flanders KC; Park SH; Thompson TC
Endocrinology; 1994 Mar; 134(3):1039-45. PubMed ID: 8119140
[TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death.
Kyprianou N; Isaacs JT
Mol Endocrinol; 1989 Oct; 3(10):1515-22. PubMed ID: 2608047
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
10. Stromal and epithelial cells from rat ventral prostate during androgen deprivation and estrogen treatment--regulation of transcription.
Bacher M; Rausch U; Goebel HW; Polzar B; Mannherz HG; Aumüller G
Exp Clin Endocrinol; 1993; 101(2):78-86. PubMed ID: 8405143
[TBL] [Abstract][Full Text] [Related]
11. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
12. Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate.
Quarmby VE; Beckman WC; Wilson EM; French FS
Mol Endocrinol; 1987 Dec; 1(12):865-74. PubMed ID: 2484717
[TBL] [Abstract][Full Text] [Related]
13. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of secondary, but not early, responding genes to phorbol ester tumor promoters in papillomas and carcinomas of mouse skin.
Hashimoto Y; Tajima O; Hashiba H; Nose K; Kuroki T
Mol Carcinog; 1990; 3(5):302-8. PubMed ID: 2123108
[TBL] [Abstract][Full Text] [Related]
15. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
16. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer.
Merz VW; Arnold AM; Studer UE
World J Urol; 1994; 12(2):96-8. PubMed ID: 7522082
[TBL] [Abstract][Full Text] [Related]
18. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
19. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.
Freeman SN; Rennie PS; Chao J; Lund LR; Andreasen PA
Biochem J; 1990 Jul; 269(1):189-93. PubMed ID: 2115769
[TBL] [Abstract][Full Text] [Related]
20. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW
Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
